The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Young Men With High-Normal Blood Pressure Have Lower Serum Adiponectin, Smaller LDL Size, and Higher Elevated Heart Rate Than Those With Optimal Blood Pressure
Open accessAbstract
OBJECTIVE—Three measures—heart rate, a global index of the influence of the autonomic nervous system on the heart; circulating concentrations of adiponectin, an adipose-specific protein; and C-reactive protein (CRP), a sensitive marker of inflammation—have been reported to be closely associated with insulin resistance. Patients with borderline hypertension are known to be more insulin resistant and dyslipidemic than those with normal blood pressure (BP). BP can be classified into three categories: optimal, normal, and high-normal. The present study examined whether those with high-normal BP have any of these three conditions as compared with those with optimal BP in young healthy men. RESEARCH DESIGN AND METHODS—Anthropometric, blood pressure, heart rate, and blood tests, including tests for adiponectin and CRP, were conducted in 198 male students, ages 18–26 years, who had fasted overnight. Insulin resistance (IR) and insulin secretion (β-cell levels) were calculated using the homeostasis model assessment (HOMA), and LDL size was measured by PAGE. RESULTS—Compared with the 90 men who had optimal BP, the 46 men with high-normal BP had increased heart rate, BMI, percent body fat, and serum leptin levels. In addition, they had greater serum insulin, HOMA IR, and β-cell levels, lower adiponectin levels, and comparable CRP levels. Furthermore, the 46 men with high-normal BP had higher serum triglyceride and apolipoprotein (apo) B levels, and smaller LDL size; however, there was no difference in LDL and HDL cholesterol and apoA-I between men with optimal and high-normal BP. After adjusting for BMI, differences were still significant in serum adiponectin, heart rate, and LDL particle size. As BP rose, there was an increase in heart rate (BMI-adjusted least square means were 63, 65, and 70 bpm in men with optimal, normal, and high-normal BP, respectively; P = 0.005), whereas serum adiponectin (7.5, 6.6, and 6.4 mg/l; P = 0.007) and LDL particle size (271, 269, and 269 Å; P = 0.008) decreased. CONCLUSIONS—Young men with high-normal BP have a faster heart rate, lower serum adiponectin levels, and smaller LDL size than men with optimal BP, even after adjustment for BMI. These results suggest the necessity of preventing further development of cardiac and metabolic diseases in young people who have high-normal BP.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915
Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity
Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J.-I., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0255 · Cited by 4,856
(1999) · Journal of Hypertension · doi:10.1097/00004872-199917020-00001 · Cited by 3,695
Weyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R. E., & Tataranni, P. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7463 · Cited by 3,541
Extension of Multiple Range Tests to Group Means with Unequal Numbers of Replications
Kramer, C. Y. (1956) · Biometrics · doi:10.2307/3001469 · Cited by 3,146
Plasma Concentrations of a Novel, Adipose-Specific Protein, Adiponectin, in Type 2 Diabetic Patients
Hotta, K., Funahashi, T., Arita, Y., Takahashi, M., Matsuda, M., Okamoto, Y., Iwahashi, H., Kuriyama, H., Ouchi, N., Maeda, K., et al. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.6.1595 · Cited by 3,133
Bonora, E., Targher, G., Alberiche, M., Bonadonna, R. C., Saggiani, F., Zenere, M. B., Monauni, T., & Muggeo, M. (2000) · Diabetes Care · doi:10.2337/diacare.23.1.57 · Cited by 2,456
Festa, A., D’Agostino, R., Howard, G., Mykkänen, L., Tracy, R. P., & Haffner, S. M. (2000) · Circulation · doi:10.1161/01.cir.102.1.42 · Cited by 2,358
Warnick, G. R., Benderson, J., & Albers, J. J. (1982) · Clinical Chemistry · doi:10.1093/clinchem/28.6.1379 · Cited by 2,159
Novel Modulator for Endothelial Adhesion Molecules: Adipocyte-Derived Plasma Protein Adiponectin
Ouchi, N., Kihara, S., Arita, Y., Maeda, K., Kuriyama, H., Okamoto, Y., Hotta, K., Nishida, M., Takahashi, M., Nakamura, T., et al. (1999) · Circulation · doi:10.1161/01.cir.100.25.2473 · Cited by 2,147
Richmond, W. (1973) · Clinical Chemistry · doi:10.1093/clinchem/19.12.1350 · Cited by 1,587
Reaven, G. M., Lithell, H., & Landsberg, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602083340607 · Cited by 1,435
Hotta, K., Funahashi, T., Bodkin, N. L., Ortmeyer, H. K., Arita, Y., Hansen, B. C., & Matsuzawa, Y. (2001) · Diabetes · doi:10.2337/diabetes.50.5.1126 · Cited by 1,072
The homeostasis model in the San Antonio Heart Study.
Haffner, S. M., Miettinen, H., & Stern, M. P. (1997) · Diabetes Care · doi:10.2337/diacare.20.7.1087 · Cited by 788
[24] Nondenaturing polyacrylamide gradient gel electrophoresis
Nichols, A. V., Krauss, R. M., & Musliner, T. A. (1986) · Methods in Enzymology · doi:10.1016/0076-6879(86)28084-2 · Cited by 521
Heart rate and the cardiovascular risk
Palatini, P., & Julius, S. (1997) · Journal of Hypertension · doi:10.1097/00004872-199715010-00001 · Cited by 505
Emoto, M., Nishizawa, Y., Maekawa, K., Hiura, Y., Kanda, H., Kawagishi, T., Shoji, T., Okuno, Y., & Morii, H. (1999) · Diabetes Care · doi:10.2337/diacare.22.5.818 · Cited by 457
Cook, D. G., Mendall, M. A., Whincup, P. H., Carey, I. M., Ballam, L., Morris, J. E., Miller, G. J., & Strachan, D. P. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00312-3 · Cited by 446
(1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-3-199802010-00001 · Cited by 385
Ledue, T. B., Weiner, D. L., Sipe, J. D., Poulin, S. E., Collins, M. F., & Rifai, N. (1998) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1177/000456329803500607 · Cited by 321
Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes
Hermans, M. P., Levy, J. C., Morris, R. J., & Turner, R. C. (1999) · Diabetologia · doi:10.1007/s001250051215 · Cited by 260
Julius, S. (1990) · JAMA · doi:10.1001/jama.264.3.354 · Cited by 256
Overweight and Hypertension: A 2-Way Street?
Julius, S., Valentini, M., & Palatini, P. (2000) · Hypertension · doi:10.1161/01.hyp.35.3.807 · Cited by 253
Hermans, M. P., Levy, J. C., Morris, R. J., & Turner, R. C. (1999) · Diabetes · doi:10.2337/diabetes.48.9.1779 · Cited by 186
High-normal blood pressure progression to hypertension in the Framingham Heart Study.
Leitschuh, M., Cupples, L. A., Kannel, W., Gagnon, D., & Chobanian, A. (1991) · Hypertension · doi:10.1161/01.hyp.17.1.22 · Cited by 169
Palatini, P., Casiglia, E., Pauletto, P., Staessen, J., Kaciroti, N., & Julius, S. (1997) · Hypertension · doi:10.1161/01.hyp.30.5.1267 · Cited by 165
Austin, M. A., Mykkänen, L., Kuusisto, J., Edwards, K. L., Nelson, C., Haffner, S. M., Pyörälä, K., & Laakso, M. (1995) · Circulation · doi:10.1161/01.cir.92.7.1770 · Cited by 164
Determination of serum triglycerides by an accurate enzymatic method not affected by free glycerol.
Sullivan, D. R., Kruijswijk, Z., West, C. E., Kohlmeier, M., & Katan, M. B. (1985) · Clinical Chemistry · doi:10.1093/clinchem/31.7.1227 · Cited by 163
Dermal Neurovascular Dysfunction in Type 2 Diabetes
Vinik, A. I., Erbas, T. A., Park, T. S., Stansberry, K. B., Scanelli, J. A., & Pittenger, G. L. (2001) · Diabetes Care · doi:10.2337/diacare.24.8.1468 · Cited by 159
Heart rate in relation to insulin sensitivity and insulin secretion in nondiabetic subjects.
Festa, A., D'Agostino, R., Hales, C. N., Mykkänen, L., & Haffner, S. M. (2000) · Diabetes Care · doi:10.2337/diacare.23.5.624 · Cited by 97
Hypertension, dyslipidemia, and insulin resistance: links in a chain or spokes on a wheel?
Hopkins, P. N., Hunt, S. C., Wu, L., Williams, G. H., & Williams, R. R. (1996) · Current Opinion in Lipidology · doi:10.1097/00041433-199608000-00011 · Cited by 92
Possible pathophysiological mechanisms for diabetic angiopathy in type 2 diabetes
Tooke, J. E. (2000) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(00)00083-0 · Cited by 88
Haffner, S. M., Mykk�nen, L., Robbins, D. C., Valdez, R., Miettinen, H., Howard, B. V., Stern, M. P., & Bowsher, R. R. (1995) · Diabetologia · doi:10.1007/bf00401766 · Cited by 85
The Autonomic Control of Heart Rate and Insulin Resistance in Young Adults
Flanagan, D., VAILE, J. C., Petley, G. W., Moore, V., Godsland, I. F., Cockington, R. A., Robinson, J. S., & Phillips, D. I. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.4.5592 · Cited by 82
Hayashi, T., Tsumura, K., Suematsu, C., Endo, G., Fujii, S., & Okada, K. (1999) · Diabetes Care · doi:10.2337/diacare.22.10.1683 · Cited by 80
Low density lipoprotein particle diameter in young, nonobese, normolipidemic Japanese men
Kazumi, T., Kawaguchi, A. T., Hozumi, T., Nagao, M., Iwahashi, M., Hayakawa, M., 石原, 健., & Yoshino, G. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(98)00201-9 · Cited by 57
Self-citationKazumi, T., Kawaguchi, A. T., Katoh, J., Iwahashi, M., & Yoshino, G. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917100-00013 · Cited by 46
Self-citationSkin microvascular vasodilatory capacity in offspring of two parents with Type 2 diabetes
Lee, B. C., Shore, A. C., Humphreys, J., Lowe, G. D. O., Rumley, A., Clark, P. M. S., Hattersley, A. T., & Tooke, J. E. (2001) · Diabetic Medicine · doi:10.1046/j.1464-5491.2001.00514.x · Cited by 20
Plasma lipoproteins. Part A: Preparation, structure, and molecular biology.
Segrest, J. P., & Albers, J. J. (1986) · PubMed · Cited by 13
Do reduced insulin sensitivity and dyslipidemia exist in borderline hypertensive patients?
Masuo, K. (1996) · American Journal of Hypertension · doi:10.1016/0895-7061(95)00296-0 · Cited by 9
Kazumi, T. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(96)06049-2 · Cited by 8
Self-citation
Cited by
The Metabolic Syndrome: Time for a Critical Appraisal
Kahn, R., Buse, J., Ferrannini, E., & Stern, M. (2005) · Diabetes Care · doi:10.2337/diacare.28.9.2289 · Cited by 2,378
A comprehensive review on metabolic syndrome
Kaur, J. (2014) · Cardiology Research and Practice · doi:10.1155/2014/943162 · Cited by 1,889
RetractedPlasma Adiponectin Levels and Risk of Myocardial Infarction in Men
Pischon, T. (2004) · JAMA · doi:10.1001/jama.291.14.1730 · Cited by 1,773
Cnop, M., Havel, P. J., Utzschneider, K. M., Carr, D. B., Sinha, M. K., Boyko, E. J., Retzlaff, B. M., Knopp, R. H., Brunzell, J. D., & Kahn, S. E. (2003) · Diabetologia · doi:10.1007/s00125-003-1074-z · Cited by 1,483
The role of the novel adipocyte-derived hormone adiponectin in human disease
Diez, J., & Iglesias, P. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1480293 · Cited by 1,114
Metadata
- Authors
- Kazumi, T., Kawaguchi, A., Sakai, K., Hirano, T., & Yoshino, G.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2002-06-01
- Volume
- 25
- Issue
- 6
- Pages
- 971-976
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2112831485
- Cited by
- 275
- References
- 42
- FWCI
- 11.41
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.